Skip to main content
. 2020 Mar 13;11(3):186. doi: 10.1038/s41419-020-2367-6

Fig. 1. Validation of human cardiac stem cells (hCSCs).

Fig. 1

Experiments were performed to validate hCSCs using company reported markers. a Immunofluorescence staining for Sca1+, MEF2C, and NKX2.5. Western blotting for MEF2C and Nkx2.5. β-actin was used as a loading control. Lane 1, 2, and 3 are three different samples. b Immunofluorescence of cardiomyocyte marker β-MHC. It is a negative control showing absence of differentiated hCSCs.